Optimizing melanoma models for ex vivo functional assays to predict targeted and immune therapy response
Optimizing melanoma models for ex vivo functional assays to predict targeted and immune therapy response
优化黑色素瘤模型进行离体功能测定，以预测靶向和免疫治疗反应
批准号：
486025
负责人：
Lin Tiffany
金额：
$1.27万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
已结题
起止时间：
2022-12-01 至 2023-12-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Melanoma is the deadliest form of skin cancer, due to its resistance to traditional cancer therapies. Major breakthroughs were made by treating advanced melanoma with two new kinds of therapies known as BRAF/MEK inhibitors and immune checkpoint inhibitors
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
